Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 340 participants.
Also called NCT07819175
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 340 participants
- Sponsor
- Registry
-
NCT07819175
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07819175. Randomized; no masking; primary purpose treatment. Start 2026-10-08 (anticipated); primary completion 2028-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed Field Ablation for the Treatment of Persistent Atrial Fibrillation: Pulmonary Vein Plus Superior Vena Cava Isolation Versus Pulmonary Vein Isolation Alone-A Prospective, Multicenter, Randomized Controlled Study
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation - pulmonary vein isolation
- Intervention (Device)
- Pulsed Field Ablation - Pulmonary Vein Isolation + Superior Vena Cava Isolation
- Lead sponsor
- Ruijin Hospital
Record details
- Record id
cardio:ct-nct07819175- Content hash
f0fe777fe032f5a639fcfa43cc465848948329bead3fa127e1f074a92a720702